Neoadjuvant radiotherapy for resectable retroperitoneal sarcoma: a meta-analysis

BACKGROUND: Neoadjuvant radiotherapy (NRT) for resectable retroperitoneal sarcoma (RPS) has been shown to be systematically feasible. Whether NRT has equivalent or better clinical effects compared to surgery alone for RPS patients remains controversial. METHODS: We performed a systematic literature...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiangji, Dong, Ruihan, Xiao, Mengmeng, Min, Li, Luo, Chenghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795731/
https://www.ncbi.nlm.nih.gov/pubmed/36578082
http://dx.doi.org/10.1186/s13014-022-02159-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795731/
https://www.ncbi.nlm.nih.gov/pubmed/36578082
http://dx.doi.org/10.1186/s13014-022-02159-3

Ejemplares similares